INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

Impact · against what's priced in

Journey Medical Corporation (DERM) faces heightened regulatory and legal risk following a securities fraud investigation and concerns over its Emrosi revenue monetization. Metropolitan Bank Holding Corp. (MCB) and Rollins, Inc. (ROL) are also under investigation by Pomerantz LLP, introducing new legal uncertainty for both companies.

DERM−0.60

No priced-in read yet